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Community-acquired pneumonia (CAP) is an important
cause of morbidity and mortality in the Asia Pacific region.1
In this region, the pathogens associated with CAP are rarely
identified.1 Nontuberculous mycobacteria (NTM), including
Mycobacterium abscessus, are increasingly recognized as
opportunistic pathogens responsible for respiratory tract
infections.2 Because NTM culture and identification is not
routinely performed in most of the Pacific islands, NTM
infections are underestimated.
To highlight the interest in identifying the etiological
agents of CAP in the Pacific, we herein present the case of
a French Polynesian man who fulfilled the American
Thoracic Society criteria2 for M. abscessus lung infection.
Signed informed consent was obtained from the patient,
and the French Polynesia Committee for Ethics approved
this study.
A 77-year-old chronic obstructive pulmonary disease
patient was admitted in May 2014 to our hospital with se-
vere hypoxemia, cough, increased sputum purulence, and
recurrent fever episodes since January 2014 after sequen-
tial amoxicillineclavulanate and moxifloxacin treatments.
A heavy ex-smoker, he received inhaled salmeterol/fluti-
casone and azithromycin long-term prophylaxis for 2 years.
Computed tomography scanner showed large bullous
emphysema and bilateral consolidations. Eight sputum
specimens were collected from May 2014 to July 2014; all
specimens were acid-fast bacilli (AFB) negative at direct
examination, four yielded AFB colonies on Lo¨w-
ensteineJensen media (bioMe´rieux, La-Balme-les-Grottes,
France) incubated at 37C in a 5% CO2 atmosphere. Isolates
were identified as M. abscessus by hybridization using
commercial probes (GenoType Mycobacterium CM/AS, Hain
Lifescience, Nehren, Germany). The identification was
confirmed by matrix-assisted laser desorption ionization-
time of flight mass spectrometry (MALDI-TOF MS) with
1.65  0.31 log scores for M. abscessus DSM 44196T (Bruker
Mycobacteria Library version v2.0, Bruker Daltonics,http://dx.doi.org/10.1016/j.jmii.2015.01.008
1684-1182/Copyright ª 2015, Taiwan Society of Microbiology. Published
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/Bremen, Germany). Further 16S ribosomal RNA, partial
rpoB gene sequencing,3 and multispacer typing4 charac-
terized the four isolates as belonging to the M. abscessus
subsp. abscessus group.
The four positive sputum specimens were not consecu-
tively collected and were identified during different pro-
cesses and thus an in-laboratory contamination was
unlikely.
As pulmonary rehabilitation (oxygen, chest physio-
therapy, and protein diet) improved the respiratory func-
tion, we decided to stop azithromycin and delay cefoxitin
and amikacin therapy. The patient left the hospital by mid-
August 2014 and 6 months after the diagnosis, the patient is
under medical surveillance for long-term follow-up, as
previously reported.5
This case illustrates that NTM should be considered as
etiological agents of CAP in the Asia Pacific region and that
M. abscessus is present in remote South Pacific islands
where it can act as an opportunistic respiratory tract
pathogen.
Culture and identification of NTM in respiratory tract
specimens is strongly advised, including rapid MALDI-TOF
MS identification, in order to guide medical management of
patients and monitoring of NTM in these tropical islands. In
addition, the identification of etiological agents of CAP may
prevent or delay the emergence of antibiotic resistance in
the Asia Pacific region.
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